SPLENOMEGALY ASSOCIATED WITH CHRONIC CONSUMPTION COAGULOPATHY
- 12 January 1974
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 195 (1-6) , 425-430
- https://doi.org/10.1111/j.0954-6820.1974.tb08164.x
Abstract
In a group of six patients suffering from various diseases accompanied by splenomegaly, low levels of factor V and fibrinogen have been observed apart from thrombo‐cytopenia. No circulating fibrin degradation products (FDP) and fibrin monomers were present and anticoagulants did not correct the coagulation disorder. However, other findings, such as the presence of fibrin deposits in the enlarged spleen, and correction of the hemostatic defect after splenectomy strongly suggest local consumption of platelets and clotting factors in the enlarged spleen. The data obtained show that a decreased concentration of clotting factors in patients with splenomegaly can be caused by local consumption alone. The absence of an elevated FDP level distinguishes our findings from those found in consumption coagulopathy accompanying diffuse intravascular clotting (DIC).This publication has 23 references indexed in Scilit:
- Splenic hemangioma with thrombocytopenia and afibrinogenemiaThe Journal of Pediatrics, 1968
- Cryptogenetic Congestive Severe Coagulopathy in SplenomegalyJAMA, 1968
- Cryptogenetic congestive severe coagulopathy in splenomegalyPublished by American Medical Association (AMA) ,1968
- Clotting-Fibrinolysis in a Cavernous HemangiomaArchives of Pediatrics & Adolescent Medicine, 1967
- The Defibrination Syndrome: Clinical Features and Laboratory DiagnosisBritish Journal of Haematology, 1967
- Gelation of Soluble Fibrin in Plasma by EthanolScandinavian Journal of Haematology, 1966
- Excessive consumption of blood coagulation components as cause of hemorrhagic diathesisThe American Journal of Medicine, 1965
- Giant Haemangioma, Thrombocytopenia, Fibrinogenopenia, and Fibrinolytic ActivityActa Medica Scandinavica, 1961
- THE MECHANISM OF CLOT DISSOLUTION BY PLASMIN*Journal of Clinical Investigation, 1959
- The Control of Dicumarol Therapy and the Quantitative Determination of Prothrombin and ProconvertinScandinavian Journal of Clinical and Laboratory Investigation, 1951